Display Settings:

Format

Send to:

Choose Destination
    Endocrinol Metab Clin North Am. 2005 Jun;34(2):385-402, ix-x.

    Screening and diagnosis of Cushing's syndrome.

    Source

    Endocrine-Diabetes Center, St. Luke's Medical Center, 2801 West KK River Parkway, Suite 245, Milwaukee, WI 53215, USA.

    Abstract

    Screening studies in high-risk populations have suggested that Cushing's syndrome is more common than previously appreciated. Patients who have specific signs and symptoms or clinical diagnoses known to be associated with hypercortisolism should be considered for screening. The measurement of late-night salivary cortisol provides the most sensitive method for screening, and urine-free cortisol and low-dose dexamethasone suppression testing may be used for confirmation of the diagnosis of endogenous hypercortisolism

    PMID:
    15850849
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk